Thu, 13 Jun 2024 | BUSINESS SALE
Knights Pharmacy has expanded with the acquisition of two sites in South Wales. The acquisition of the sites in Abercarn and Cwmcarn, previously owned by Evans Group, was backed by a funding package from HSBC UK.
The Abercarn site dispenses approximately 12,000 items annually, while the Cwmcarn site issues around 5,000. Following the deal, Knights intends to enhance services at the Abercarn pharmacy through the opening of an additional treatment room.
Knights also plans to continue offering independent prescribing services at both pharmacies, enabling pharmacists to prescribe medicines for minor illnesses.
The acquisition means that Knights has grown from operating 18 community pharmacies in 2021 to now having 49 sites across England and Wales. The firm’s sites are generally high volume and well-established in their communities, collectively dispensing well in excess of six million items per year.
Knights Pharmacy Managing Director Anand Sodha (pictured above, right) commented: “We‘ve successfully built our presence across South Wales and the West Midlands over the past number of years.”
“Our plan for these two additional sites, and for the rest of our locations, is to focus on continually bettering our services. By offering vital treatment for minor ailments, we can help to alleviate the pressure on the NHS and ensure our customers receive the care they need.”
HSBC UK Relationship Director for West Midlands MME Partho Bose (pictured above, left) added: “Knights Pharmacy’s commitment to community health and its vision for growth aligns with our goal of backing ambitious businesses. We look forward to seeing the positive impact these acquisitions will have on local communities in South Wales.”
Find out more about emerging dealmaking trends in the UK's pharmacy market
We are delighted to bring this thriving cosmetic surgery clinic to the market. Located in London’s prestigious medical district, Harley Street, this CQC-registered business specialises in a wide range of plastic surgery procedures.
This growing clinical research facility is focused on late-phase clinical trials, the business has secured important contracts with top pharmaceutical companies, making it an attractive opportunity for those looking to invest in the expanding field o...
This is an exclusive chance to acquire a renowned cardiology practice situated in the prestigious London medical district.
LEASEHOLD
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.